Detalhe da pesquisa
1.
Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome.
JCO Glob Oncol
; 7: 1141-1150, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270331